Antibodies Directed against Lewis-Y Antigen Inhibit Signaling of Lewis-Y Modified ErbB Receptors
Markus Klinger(Medical University of Vienna), Veronika Sexl(University of Veterinary Medicine Vienna)
Cited by 66
Related Papers
High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia
|Blood|2011|187
Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis
|Nature Communications|2017|176
A kinase-independent role for CDK8 in BCR-ABL1+ leukemia
|Nature Communications|2019|73
Loss of JAK1 Drives Innate Immune Deficiency
|Frontiers in Immunology|2019|54